Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has provided an update.
Insignia Financial Ltd has announced a change in its substantial holding in Botanix Pharmaceuticals Limited. As of January 9, 2025, Insignia’s voting power in Botanix has decreased from 10.34% to 9.32%, reflecting a shift in their investment position. This change may impact Botanix’s shareholder composition and market perception, potentially influencing future strategic decisions within the company.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of dermatological products. The company is involved in innovative drug delivery systems and treatments for skin diseases, aiming to address unmet medical needs in the dermatology market.
YTD Price Performance: 12.64%
Average Trading Volume: 5,200,781
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$867.2M
For an in-depth examination of BOT stock, go to TipRanks’ Stock Analysis page.
